|Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis|
OM Gutiérrez, M Mannstadt, T Isakova, JA Rauh-Hain, H Tamez, A Shah, ...
New England Journal of Medicine 359 (6), 584-592, 2008
|FGF23 induces left ventricular hypertrophy|
C Faul, AP Amaral, B Oskouei, MC Hu, A Sloan, T Isakova, OM Gutiérrez, ...
The Journal of clinical investigation 121 (11), 2011
|Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease|
T Isakova, P Wahl, GS Vargas, OM Gutiérrez, J Scialla, H Xie, D Appleby, ...
Kidney international 79 (12), 1370-1378, 2011
|Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease|
O Gutierrez, T Isakova, E Rhee, A Shah, J Holmes, G Collerone, ...
Journal of the American Society of Nephrology 16 (7), 2205-2215, 2005
|Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease|
T Isakova, H Xie, W Yang, D Xie, AH Anderson, J Scialla, P Wahl, ...
Jama 305 (23), 2432-2439, 2011
|KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD|
LA Inker, BC Astor, CH Fox, T Isakova, JP Lash, CA Peralta, MK Tamura, ...
American Journal of Kidney Diseases 63 (5), 713-735, 2014
|Fibroblast growth factor-23 and left ventricular hypertrophy in chronic kidney disease|
OM Gutiérrez, JL Januzzi, T Isakova, K Laliberte, K Smith, G Collerone, ...
Circulation 119 (19), 2545, 2009
|Phosphorus binders and survival on hemodialysis|
T Isakova, OM Gutierrez, Y Chang, A Shah, H Tamez, K Smith, ...
Journal of the American Society of Nephrology 20 (2), 388-396, 2009
|Fibroblast growth factor-23 and cardiovascular events in CKD|
JJ Scialla, H Xie, M Rahman, AH Anderson, T Isakova, A Ojo, X Zhang, ...
Journal of the American Society of Nephrology 25 (2), 349-360, 2014
|Fibroblast growth factor 23 is not associated with and does not induce arterial calcification|
JJ Scialla, WL Lau, MP Reilly, T Isakova, HY Yang, MH Crouthamel, ...
Kidney international 83 (6), 1159-1168, 2013
|Fibroblast growth factor 23 and Inflammation in CKD|
JM Mendoza, T Isakova, AC Ricardo, H Xie, SD Navaneethan, ...
Clinical Journal of the American Society of Nephrology 7 (7), 1155-1162, 2012
|Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production|
V David, A Martin, T Isakova, C Spaulding, L Qi, V Ramirez, ...
Kidney international 89 (1), 135-146, 2016
|New susceptibility loci associated with kidney disease in type 1 diabetes|
N Sandholm, RM Salem, AJ McKnight, EP Brennan, C Forsblom, ...
PLoS Genet 8 (9), e1002921, 2012
|Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active|
T Shimada, I Urakawa, T Isakova, Y Yamazaki, M Epstein, ...
The Journal of Clinical Endocrinology & Metabolism 95 (2), 578-585, 2010
|Post-transplant hypophosphatemia: tertiary ‘hyper-phosphatoninism’?|
I Bhan, A Shah, J Holmes, T Isakova, O Gutierrez, SA Burnett, H Jüppner, ...
Kidney international 70 (8), 1486-1494, 2006
|Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease|
T Isakova, OM Gutiérrez, K Smith, M Epstein, LK Keating, H Jüppner, ...
Nephrology Dialysis Transplantation 26 (2), 584-591, 2011
|Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD|
T Isakova, O Gutierrez, A Shah, L Castaldo, J Holmes, H Lee, M Wolf
Journal of the American Society of Nephrology 19 (3), 615-623, 2008
|Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease|
MM McGrath, T Isakova, HG Rennke, AM Mottola, KA Laliberte, JL Niles
Clinical Journal of the American Society of Nephrology 6 (12), 2799-2805, 2011
|KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone …|
T Isakova, TL Nickolas, M Denburg, S Yarlagadda, DE Weiner, ...
American Journal of Kidney Diseases 70 (6), 737-751, 2017
|Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD|
T Isakova, A Barchi-Chung, G Enfield, K Smith, G Vargas, J Houston, ...
Clinical Journal of the American Society of Nephrology 8 (6), 1009-1018, 2013